XML 69 R58.htm IDEA: XBRL DOCUMENT v3.24.3
SCHEDULE OF OPERATIONS, ASSETS AND CAPITAL EXPENDITURES FOR OUR BUSINESS SEGMENTS (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Segment Reporting Information [Line Items]                
Net revenue $ 21,671,599     $ 16,024,948     $ 60,367,060 $ 47,300,029
Gross profit (loss) 19,679,612     14,273,599     54,476,341 41,235,505
Selling, general and administrative expenses 18,993,255     13,877,879     54,143,122 40,658,424
Research and development 1,359,530     986,454     3,291,479 3,480,906
Depreciation and amortization 1,103,854     997,674     3,314,781 2,580,243
Interest expense 927,577     188,294     1,839,259 188,300
Net income (loss) (2,883,052) $ (3,529,202) $ (1,799,043) (1,094,949) $ (1,866,180) $ (1,216,329) (8,211,297) (4,177,458)
Segment EBITDA 841,961     266,792     1,745,566 (321,662)
Segment assets (at period end) [1] 88,545,476     73,871,149     88,545,476 73,871,149
Expenditures for long-lived assets 9,096     170,320     133,676 210,970
Sanara Surgical [Member]                
Segment Reporting Information [Line Items]                
Net revenue 21,671,599     16,024,948     60,367,060 47,297,299
Gross profit (loss) 19,679,612     14,273,599     54,476,341 41,241,740
Selling, general and administrative expenses 17,420,346     13,460,404     51,453,311 39,229,030
Research and development 783,840     225,886     1,945,263 669,849
Depreciation and amortization 696,888     590,563     2,093,797 1,359,180
Interest expense 927,577     188,294     1,839,259 188,300
Net income (loss) (180,488)     567,235     (2,872,286) 1,181,296
Segment EBITDA 2,563,521     1,400,916     5,095,670 3,766,196
Segment assets (at period end) [1] 67,037,973     45,715,495     67,037,973 45,715,495
Expenditures for long-lived assets 9,096     170,320     133,676 210,970
THP [Member]                
Segment Reporting Information [Line Items]                
Net revenue         2,730
Gross profit (loss)         (6,235)
Selling, general and administrative expenses 1,572,909     417,475     2,689,811 1,429,394
Research and development 575,690     760,568     1,346,216 2,811,057
Depreciation and amortization 406,966     407,111     1,220,984 1,221,063
Interest expense        
Net income (loss) (2,702,564)     (1,662,184)     (5,339,011) (5,358,754)
Segment EBITDA (1,721,560)     (1,134,124)     (3,350,104) (4,087,858)
Segment assets (at period end) [1] 21,507,503     28,155,654     21,507,503 28,155,654
Expenditures for long-lived assets        
[1] - Segment assets for 2023 represent assets as of December 31, 2023.